制药算法对上胃肠道症状患者的影响:干预前后研究
María Puig-Moltó1, Blanca Lumbreras2, Juan Manuel Mendive3
1Department of Public Health, History of Science and Gynecology, Miguel Hernandez University, San Juan de Alicante, Spain.
Preventive medicine
|February 5, 2024
概括
一个新的算法改善了患者的上部胃肠道症状,提高了他们的生活质量. 社区药房干预措施对患者报告的结果和对护理的满意度产生了积极的影响.
科学领域:
- 药房实践 在药房实践.
- 胃肠病学 胃肠病学
- 健康 结果 研究 研究 结果
背景情况:
- 上部胃肠道症状显著影响患者的生活质量.
- 社区药房在管理共同的健康状况方面发挥着至关重要的作用.
- 需要一个验证的算法来标准化对上部胃肠道问题的护理.
研究的目的:
- 评估一种新算法的对上部胃肠道患者症状和对药物护理的满意度的影响.
- 评估算法的有效性,以改善患者报告的结果指标 (PROM) 和患者报告的经验指标 (PREM).
主要方法:
- 一项介入前后的研究,涉及西班牙134家社区药房的1221名患者.
- 患者根据症状类型 (腹膜,背膜,重叠) 进行分类,使用胃食道逆流性疾病影响量表 (GIS).
- 干预措施包括医疗转诊,生活方式教育和非处方药 (OTC) 或非药物处方,随访14天.
主要成果:
- 在患者的GIS得分显著改善被观察到后背 (p < 0.001) 和重叠症状 (p < 0.001),但没有表胃症状.
- 包括健康习惯教育和特定药物治疗 (抗酸药,酸盐-抗酸药) 在内的干预措施导致GIS分数得到改善.
- 患者对药物护理的满意度超过了99.2%.
结论:
- 实施的上部胃肠道症状算法对患者的症状和生活质量产生了积极的影响.
- 使用该算法的基于社区药房的干预措施显著提高了患者对所接受护理的满意度.
- 该算法表明,它是一个有价值的工具,可以增强医药护理的价值,用于管理上部胃肠道疾病.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
175
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
175
Peptic Ulcer Disease IV: Management
93
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
93
Factors Influencing Drug Absorption: Disease States and Pharmacology
516
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
516
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
260
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
260
Drugs for Treatment of Constipation-Predominant IBS
169
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
169
Factors Influencing Drug Absorption: Presystemic Elimination
219
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
219


